# Safety and Efficacy Study of SHAPE Gel in Alopecia Areata

> **NCT02636244** · PHASE2 · UNKNOWN · sponsor: **TetraLogic Pharmaceuticals** · enrollment: 40 (estimated)

## Conditions studied

- Alopecia Areata

## Interventions

- **DRUG:** SHAPE Gel

## Key facts

- **NCT ID:** NCT02636244
- **Lead sponsor:** TetraLogic Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-02
- **Primary completion:** 2017-08
- **Final completion:** 2018-01
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2016-10-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02636244

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02636244, "Safety and Efficacy Study of SHAPE Gel in Alopecia Areata". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02636244. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*